I am not a very smart person (just saying this up front for those that will tell me how stupid I am) but, Myopia is now treated with Lasik Surgery on folks that can see but chose to not wear glasses. A couple of years ago the FDA was so concerned about putting stem cells in blind peoples eyes that they limited the number of people that could get stem cells and they would only let ACTC treat people that were legally blind and then with very small amounts of stem cells. Today it was announced that the FDA will allow people with Myopia (which can be corrected with glasses (non-invasive treatment) or Lasik surgery) to receive stem cells injections in their eyes (I am assuming that they will be injected in the new study). To me, that is not a little step, that is a giant leap. Am I missing something here?
Sentiment: Strong Buy
You'll always be smarter than most people on this board simply because you admittted you don't think you are that smart. Watch how many times these fools call people dummy and whatever as they spew nothing but idiocy and pseudo intellectualism. As far as the approval goes, I'm very curious to see how/if stem cells can correct myopia. Lasix got slammed through quickly because there was a ton of money behind it, even with it's somewhat high failure rate even to this day. Let's see how this developes.
I am very stupid but myopia is rampant in china and Japan some estimates go as high as 80 percent and that makes them more susceptable to a form macular degeneration so being able to treat it is a big deal.
Is myopia more prevalent in China/Japan, because they read more? Maybe it is due to their way of printing characters? I occasionally work with a Chinese woman and I believe it is nearly impossible for someone with less than perfect eyesight to read their printed words! Little wonder they often wear thick lensed glasses!
As a suffering of macular degeneration from severe myopia, I don't think the trial is to cure myopia but to address the type of macular degeneration caused by severe myopia. This type of degeneration varies from the dry type.
It's to treat and I think you're right, it's about the fissures.
The primary focus of the study will be to evaluate the safety in patients with severe myopia of the type that causes fissures in the RPE layer of the eye.